Performance Data

Performance Data

Below are key performance indicators (KPIs) for each of our four focus areas (Access to Health, Employees, Environmental Sustainability, and Ethics & Transparency), as well as links to the performance data tables found throughout this site.

 

These KPIs serve as baseline measurements for our corporate responsibility activities, are measured globally unless otherwise noted, and cover all of our business units with the exception of joint ventures.

Access to Health

KPIs1

Research & Development2012 2013 2014 2015 2016
Top 20 global burdens of illness addressed by our products and pipeline255% 88% 88% 88% 88%
GCP/PV audits by regulatory agencies or clinical trial investigators that led to significant fines, penalties, warning letters or product seizures*0 - 0 0 -
Established significant external licenses and collaborations361 40 35 64 57
Narrative of compounds provided to product-development partnerships4 Link
* Complete response letter received for Sugammadex (MK-8616) in 2013 and complete response letter received for Januvia (sitagliptin; MK-0431) in 2016.
Manufacturing & Supply2012 2013 2014 2015 2016
Annual percentage of units manufactured/sold and recalled during a given year (recall rate globally)5, 60.19% 0.11% 0.22% 0.07% 0.01%
Number of local and regional manufacturing partnerships to enable access84 68 104 179 179
Number of products available by local and regional partnerships734 354 499 1,157 941
Registration2012 2013 2014 2015 2016
New product and device registrations8, 9, 10204 179 176 156 143
Local regulatory agency GCP/PV training requests fulfilled that will help strengthen agency capabilities with their GCP/PV compliance oversight role11 Link
Products submitted that have achieved WHO prequalification10 11 11 11 11
Pricing & Commercialization2012 2013 2014 2015 2016
Number of products which are supported with differential pricing12, 13NA 24 35 35 40
Number of low and lower-middle income countries where inter- and/or intra-country pricing has been implemented14NA 70 114 121 123
Investment in patient- and provider-education programs (in millions)$71.4 $61.3 $52.3 $80.0 $80.2
Community Investment2012 2013 2014 2015 2016
Health care workers trained through major programs and partnerships1538,000 22,000 137,000 18,669 32,218
Investment in partnerships for activities to address underlying barriers to health, such as health-system strengthening and capacity building (in millions)15$24 $24 $32 $31 $28
People reached through major programs & partnerships (in millions)15269 302 267 188 293
NA: Not available.
1. Unless otherwise stated, data for Access to Health are reflective of our Human Health business only; information on our company's Animal Health is reported separately.
2. As defined by the Institute for Health Metrics and Evaluation (IHME), which replaces the previously used WHO chart of leading causes of disease, condition or injury.
3. Starting in 2014, this metric no longer includes select early licenses and research collaborations that were included in the metric for previous years.
4. For information on product-development partnerships, visit the Research & Development page.
5. Definition of Recall Classifications: http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm049070.htm#RecallClassifications.
6. Beginning in 2014, product recalls include data from our Animal Health business.
7. Increase represented in 2015 is due in part by better visibility to global partner information.
8. Data includes new products and new indications.
9. For information on new registrations by region, visit our Clinical Research page.
10. Data for all years have been updated based on a tracking system upgrade that corrected miscounts in prior years.
11. For information on local regulatory agency GCP/PV training requests, visit our Clinical Research page.
12. Differential pricing intended to facilitate access for the at-need population.
13. Products include HIV treatments, vaccines and other patented products.
14. Countries as defined by the World Bank 2013 GNI Classification, including UN-defined Least Developed Countries.
15. Includes investments by the Office of Corporate Responsibility, MSD for Mothers and/or our company's Foundation.

Employees

KPIs

Diversity & Inclusion2012 2013 2014 2015 2016
Women in executive roles131% 31% 31% 34% 31%
Women on the Board 17% 17% 17% 21% 23%
Members of underrepresented ethnic groups on the Board25% 25% 25% 21% 23%
Members of underrepresented ethnic groups in executive roles (U.S.) 17% 20% 20% 20% 23%
Members of underrepresented ethnic groups in the workforce (U.S.)24% 24% 24% 26% 26%
Well-Being2012 2013 2014 2015 2016
Response rate to the Voice Survey77% 77% 78% NA 85%
Employees who completed a health assessment (U.S.)58% 62% 57% 58% 57%
Lost-time incident rate (LTIR)0.27 0.28 0.20 0.21 0.13
Recordable injury rate (RIR)0.62 0.61 0.57 0.47 0.35
Volunteerism2012 2013 2014 2015 2016
Employees who took release time according to the global policy on employee volunteerism2NA NA NA 9% 21%
Total recorded volunteer hours3NA NA 109,932 80,585 214,862
NA: Not available.
1. “Executive” is defined as the chief executive officer and two structural levels below.
2. Figures involve some estimate where specific data was not available.
3. 2016 figures are based on employee self-recorded volunteer hours and volunteer hours communicated directly to the Office of Corporate Responsibility for certain countries. 2015 marked the first year in which volunteer-hour reporting was based solely on employee self-reporting. Prior years included estimates for unrecorded volunteer hours.

Environmental Sustainability1

KPIs

2012 2013 2014 2015 2016
Greenhouse gas emissions (Scope 1 & 2) (MT CO2e)21,856,000 1,760,000 1,630,700 1,501,000 1,409,600
Water usage (billion gallons)8.6 7.5 7.1 6.3 5.5
Operational waste generated (MT)109,470 96,256 83,733 69,856 72,599
1. Includes facilities worldwide.
2. In accordance with the Greenhouse Gas Protocol, prior-year data have been adjusted to add or remove facilities that have been acquired or sold. Adjustments also reflect changes in methodology to ensure consistency from year to year.

Ethics & Transparency

KPIs

2012 2013 2014 2015 2016
Employees trained on our Code of Conduct92% 99% 99% 99% 100%
Ratio of substantiated allegations to concerns/issues raised 60% 58% 60% 58% 55%
Reported concerns regarding privacy practices, breaches of privacy and losses of personal data and devices that were substantiated123% 26% 18% 96% 98%
1. Privacy concerns include all concerns escalated to our Privacy Office about the company’s privacy practices. Substantiated concerns are those that are determined to be inconsistent with our privacy standards or that involve the loss of, theft of or unauthorized access to personal data.

Economic Impact